Mitchell A. Psotka

4.9k total citations · 3 hit papers
91 papers, 1.9k citations indexed

About

Mitchell A. Psotka is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Mitchell A. Psotka has authored 91 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 25 papers in Surgery and 24 papers in Biomedical Engineering. Recurrent topics in Mitchell A. Psotka's work include Heart Failure Treatment and Management (39 papers), Mechanical Circulatory Support Devices (23 papers) and Cardiovascular Function and Risk Factors (17 papers). Mitchell A. Psotka is often cited by papers focused on Heart Failure Treatment and Management (39 papers), Mechanical Circulatory Support Devices (23 papers) and Cardiovascular Function and Risk Factors (17 papers). Mitchell A. Psotka collaborates with scholars based in United States, Germany and United Kingdom. Mitchell A. Psotka's co-authors include John R. Teerlink, Ramesh Singh, Carolyn Rosner, Behnam Tehrani, Alexander G. Truesdell, Christopher M. O’Connor, Tom G. Obrig, Tiffany R. Keepers, Larry A. Allen and Shashank S. Sinha and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Mitchell A. Psotka

86 papers receiving 1.9k citations

Hit Papers

Standardized Team-Based Care for Cardiogenic Shock 2019 2026 2021 2023 2019 2020 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Standardized Team-Based Care for Cardiogenic Shock
    2019 280 citations Shashank Desai, Ramesh Singh et al. Journal of the American College of Cardiology profile →
  2. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock
    2020 204 citations Mitchell A. Psotka, Ramesh Singh et al. JACC Heart Failure profile →
  3. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
    2022 119 citations Jan Biegus, Adriaan A. Voors et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell A. Psotka United States 23 989 598 552 462 320 91 1.9k
David P. Nelson United States 23 461 0.5× 215 0.4× 409 0.7× 269 0.6× 72 0.2× 63 1.7k
Stephanie Neuhold Austria 22 1.2k 1.2× 75 0.1× 373 0.7× 162 0.4× 226 0.7× 62 2.1k
Simon J. Finney United Kingdom 19 392 0.4× 536 0.9× 528 1.0× 640 1.4× 660 2.1× 54 2.7k
V.‐P. Harjola Finland 10 1.6k 1.6× 229 0.4× 205 0.4× 233 0.5× 85 0.3× 19 1.9k
Dipanjan Banerjee United States 21 393 0.4× 468 0.8× 538 1.0× 206 0.4× 201 0.6× 77 1.3k
Debra Egan United States 17 541 0.5× 123 0.2× 542 1.0× 572 1.2× 435 1.4× 26 1.9k
Marjut Varpula Finland 20 530 0.5× 200 0.3× 612 1.1× 360 0.8× 94 0.3× 32 1.9k
Filomena Regina Barbosa Gomes Galas Brazil 21 526 0.5× 191 0.3× 697 1.3× 345 0.7× 114 0.4× 85 2.4k
Jean-François Marquis Canada 27 1.7k 1.7× 137 0.2× 946 1.7× 320 0.7× 61 0.2× 62 2.5k
Рамазан Оздемир Türkiye 27 804 0.8× 150 0.3× 481 0.9× 92 0.2× 52 0.2× 138 2.1k

Countries citing papers authored by Mitchell A. Psotka

Since Specialization
Citations

This map shows the geographic impact of Mitchell A. Psotka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Psotka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Psotka more than expected).

Fields of papers citing papers by Mitchell A. Psotka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell A. Psotka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Psotka. The network helps show where Mitchell A. Psotka may publish in the future.

Co-authorship network of co-authors of Mitchell A. Psotka

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell A. Psotka. A scholar is included among the top collaborators of Mitchell A. Psotka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell A. Psotka. Mitchell A. Psotka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Southworth, Mary, et al.. (2025). Responder Analyses Can Be Misleading. Journal of the American College of Cardiology. 85(2). 196–198. 2 indexed citations
2.
Cunningham, Jonathan W., William T. Abraham, Ankeet S. Bhatt, et al.. (2024). Artificial Intelligence in Cardiovascular Clinical Trials. Journal of the American College of Cardiology. 84(20). 2051–2062. 11 indexed citations
3.
Jhund, Pardeep S., Mitchell A. Psotka, Trejeeve Martyn, et al.. (2024). Where's the Remote? Failure to Report Clinical Workflows in Heart Failure Remote Monitoring Studies. Journal of Cardiac Failure. 31(9). 1420–1429. 1 indexed citations
4.
Shah, Palak, G. Sayer, Shashank S. Sinha, et al.. (2024). Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients. JACC Heart Failure. 12(11). 1898–1912. 2 indexed citations
5.
Savarese, Gianluigi, JoAnn Lindenfeld, Davide Stolfo, et al.. (2023). Use of Patient-Reported Outcomes in Heart Failure: From Clinical Trials to Routine Practice. European Journal of Heart Failure. 25(2). 139–151. 27 indexed citations
6.
Greene, Stephen J., Eric J. Velazquez, Kevin J. Anstrom, et al.. (2023). Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. Circulation. 148(2). 124–134. 10 indexed citations
7.
Pocock, Stuart, João Pedro Ferreira, Timothy Collier, et al.. (2023). The Win Ratio Method in Heart Failure Trials: Lessons Learnt from EMPULSE. European Journal of Heart Failure. 25(5). 632–641. 19 indexed citations
8.
Ferreira, João Pedro, Jon Blatchford, John R. Teerlink, et al.. (2023). Mineralocorticoid Receptor Antagonist Use and the Effects of Empagliflozin on Clinical Outcomes in Patients Admitted for Acute Heart Failure: Findings from EMPULSE. European Journal of Heart Failure. 25(10). 1797–1805. 6 indexed citations
9.
Lala, Anuradha, Carine Hamo, Biykem Bozkurt, et al.. (2023). Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies. JACC Heart Failure. 12(1). 1–15. 11 indexed citations
10.
Cooper, Lauren B., Mitchell A. Psotka, Robert J. Mentz, et al.. (2022). Proteomic differences among patients with heart failure taking furosemide or torsemide. Clinical Cardiology. 45(3). 265–272. 5 indexed citations
11.
Kosiborod, Mikhail, Christiane E. Angermann, Sean P. Collins, et al.. (2022). Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Circulation. 146(4). 279–288. 93 indexed citations
12.
Wang, Lu, Ramesh Singh, Stephan Schueler, et al.. (2021). LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events. The Journal of Heart and Lung Transplantation. 40(12). 1560–1570. 17 indexed citations
13.
Tang, Gilbert H.L., Rodrigo Estévez‐Loureiro, Yang Yu, et al.. (2021). Survival Following Edge‐to‐Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis. Journal of the American Heart Association. 10(8). e019882–e019882. 32 indexed citations
14.
Anchouche, Khalil, Malik Elharram, Robert Avram, et al.. (2021). Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review. Canadian Journal of Cardiology. 37(9). 1438–1449. 20 indexed citations
15.
Bhatt, Ankeet S., William T. Abraham, JoAnn Lindenfeld, et al.. (2020). Treatment of HF in an Era of Multiple Therapies. JACC Heart Failure. 9(1). 1–12. 18 indexed citations
16.
Shah, Palak, Lauren B. Cooper, Mitchell A. Psotka, et al.. (2019). Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis. The Journal of Heart and Lung Transplantation. 38(7). 721–730. 24 indexed citations
17.
Psotka, Mitchell A., Mona Fiuzat, Peter E. Carson, et al.. (2019). Design of a “Lean” Case Report Form for Heart Failure Therapeutic Development. JACC Heart Failure. 7(11). 913–921. 8 indexed citations
18.
Psotka, Mitchell A., et al.. (2017). Palliative Care in Heart Failure: What Triggers Specialist Consultation?. Progress in Cardiovascular Diseases. 60(2). 215–225. 21 indexed citations
19.
Psotka, Mitchell A., Sonia Sharma, Van Selby, et al.. (2016). Abstract 17522: Home Monitoring is Associated With Fewer Hospital Readmissions Following Left Ventricular Assist Device Implantation. Circulation. 3 indexed citations
20.
Psotka, Mitchell A., Sonia Sharma, Van Selby, et al.. (2016). Abstract 19132: Home Monitoring is Associated With Fewer Gastrointestinal Bleeding Events Following Left Ventricular Assist Device Implantation. Circulation. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Nelson Breakdown of academic impact, for papers by Stephanie Neuhold Breakdown of academic impact, for papers by Simon J. Finney Breakdown of academic impact, for papers by V.‐P. Harjola Breakdown of academic impact, for papers by Dipanjan Banerjee Breakdown of academic impact, for papers by Debra Egan Breakdown of academic impact, for papers by Marjut Varpula Breakdown of academic impact, for papers by Filomena Regina Barbosa Gomes Galas Breakdown of academic impact, for papers by Jean-François Marquis Breakdown of academic impact, for papers by Рамазан Оздемир
Rankless by CCL
2026